Home › Colorectal Cancer › California › Newport Beach
Colorectal Cancer clinical trials in Newport Beach, CA
6 studies for Colorectal Cancer are looking for participants at sites in and around Newport Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
RecruitingPhase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RecruitingPhase 1
- Research Site, Newport Beach
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
RecruitingPhase 1
- Research Site, Newport Beach
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecruitingPhase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
Recruiting
- City of Hope at Newport Beach Fashion Island, Newport Beach
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
RecruitingPhase 2
- Hoag Memorial Hospital Presbyterian, Newport Beach
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX102 studies
- New York City, NY78 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA59 studies
- Arlington, VA52 studies
- St. Louis, MO50 studies
- San Antonio, TX46 studies
- Philadelphia, PA44 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA37 studies
- Chicago, IL34 studies
Other studies in Newport Beach
- Breast Cancer16 studies
- Non-Small Cell Lung Cancer14 studies
- Metastatic Cancer10 studies
- COPD9 studies
- Ovarian Cancer9 studies
- Endometrial Cancer7 studies
- Lung Cancer7 studies
- Prostate Cancer6 studies
- Triple-Negative Breast Cancer6 studies
- Cancer (all types)6 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.